Loading...
News
    Shows

      Arthritis Drugs Scrutinized

      |After drug maker Merck yanked the popular anti-arthritis drug Vioxx off the shelves citing heart risks, other similar drugs are under increased scrutiny, Elizabeth Kaledin reports.

      Related Videos

      You Might Like

      Comments